Literature DB >> 30767871

Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.

Yukiko Takakuwa1, Hironari Hanaoka2, Tomofumi Kiyokawa1, Harunobu Iida1, Kana Ishimori1, Toshimasa Uekusa3, Hidehiro Yamada4, Kimito Kawahata1.   

Abstract

OBJECTIVES: Adult-onset Still's disease (AOSD) is an inflammatory disorder characterised by sustained fevers, arthritis, and skin involvement. Interstitial lung disease (ILD) is a rare manifestation, and its clinical characteristics have yet to be determined.
METHODS: We sought to examine the clinical characteristics of AOSD-associated ILD. We retrospectively investigated 78 patients diagnosed as AOSD. ILD was diagnosed based on chest high-resolution computed tomography (HRCT). Clinical characteristics were compared between patients with and without ILD. Relapse was defined as sustained fevers, re-emergence of arthritis, and skin involvement after remission. We further investigated the pathological features of ILD on available samples.
RESULTS: Patients with ILD, found in 9 of 78 (11.5 %), had older age of onset (mean age 62.6) than those without ILD (mean age 38.8) (p<0.01). The 3-year survival rates were comparable between patients with ILD (92.5%) and those without ILD (88.9%) (p=0.23). Patients with ILD had a higher cumulative rate of haemophagocytic syndrome (HPS) and relapse than those without (p<0.0001 and p=0.009, respectively). Chest HRCT showed marked thickening of the interlobular septa, the bronchovascular bundles, or the visceral pleura in all cases. There was no honeycomb or volume loss. Pulmonary pathological findings revealed marked thickening of the visceral pleura and the interlobular septa.
CONCLUSIONS: Patients with ILD might have higher risks for HPS and relapse. Careful observation and appropriate therapeutic intervention might be needed.

Entities:  

Year:  2019        PMID: 30767871

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.

Authors:  Ruxue Yin; Gangjian Wang; Xiaopei Yang; Lei Zhang; Shuolin Wang; Tianfang Li; Shengyun Liu
Journal:  Clin Rheumatol       Date:  2021-05-18       Impact factor: 2.980

2.  Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.

Authors:  Ilenia Di Cola; Federico Bruno; Onorina Berardicurti; Riccardo Monti; Alessandro Conforti; Alessandra Di Sibio; Viktoriya Pavlych; Carlo Masciocchi; Antonio Barile; Paola Cipriani; Piero Ruscitti
Journal:  Clin Rheumatol       Date:  2021-04-14       Impact factor: 2.980

3.  Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.

Authors:  Aleksander Lenert; GYeon Oh; Michael J Ombrello; Sujin Kim
Journal:  Rheumatology (Oxford)       Date:  2020-07-01       Impact factor: 7.580

Review 4.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16

Review 5.  Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.

Authors:  Beatrice Maranini; Giovanni Ciancio; Marcello Govoni
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.